Research is ongoing to modulate ABCB1 expression and P-glycoprotein activity to overcome drug resistance and improve therapeutic outcomes. Strategies include using inhibitors or modulators to block P-gp function, thereby increasing the intracellular concentration of chemotherapeutic agents in resistant cancer cells. Additionally, understanding the signaling pathways that regulate ABCB1 expression could provide new targets for intervention.
